Epigenetic modifications in valproic acid-induced teratogenesis.
Exposure to the anticonvulsant drug valproic acid (VPA) in utero is associated with a 1-2% increase in neural tube defects (NTDs), however the molecular mechanisms by which VPA induces teratogenesis are unknown. Previous studies demonstrated that VPA, a direct inhibitor of histone deacetylase, can induce histone hyperacetylation and other epigenetic changes such as histone methylation and DNA demethylation. The objective of this study was to determine if maternal exposure to VPA in mice has the ability to cause these epigenetic alterations in the embryo and thus contribute to its mechanism of teratogenesis. Pregnant CD-1 mice (GD 9.0) were administered a teratogenic dose of VPA (400mg/kg, s.c.) and embryos extracted 1, 3, 6, and 24h after injection. To assess embryonic histone acetylation and histone methylation, Western blotting was performed on whole embryo homogenates, as well as immunohistochemical staining on embryonic sections. To measure DNA methylation changes, the cytosine extension assay was performed. Results demonstrated that a significant increase in histone acetylation that peaked 3h after VPA exposure was accompanied by an increase in histone methylation at histone H3 lysine 4 (H3K4) and a decrease in histone methylation at histone H3 lysine 9 (H3K9). Immunohistochemical staining revealed increased histone acetylation in the neuroepithelium, heart, and somites. A decrease in methylated histone H3K9 staining was observed in the neuroepithelium and somites, METHYLATED histone H3K4 staining was observed in the neuroepithelium. No significant differences in global or CpG island DNA methylation were observed in embryo homogenates. These results support the possibility that epigenetic modifications caused by VPA during early mouse organogenesis results in congenital malformations.
Tung
Emily W Y
EW
Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario K7L3N6, Canada.
Winn
Louise M
LM
D000014:Abnormalities, Drug-Induced / Q000196:embryology* / Q000235:genetics / Q000378:metabolism; D000107:Acetylation / Q000187:drug effects; D000818:Animals; D044127:Epigenesis, Genetic / Q000187:drug effects* / Q000502:physiology*; D005260:Female; D006657:Histones / Q000378:metabolism; D051379:Mice; D009436:Neural Tube Defects / Q000139:chemically induced / Q000196:embryology / Q000378:metabolism; D011247:Pregnancy; D014635:Valproic Acid / Q000633:toxicity*
D006657:Histones; D014635:Valproic Acid